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One sentence summary:  Host and parasite RNA-sequencing is combined with parasite load 26 
estimates to reveal mechanisms associated with human severe malaria.    27 
 28 
Abstract  29 
The pathogenesis of infectious diseases depends on the interaction of host and pathogen. In 30 
Plasmodium falciparum malaria, host and parasite processes can be assessed by dual RNA-31 
sequencing of blood from infected patients. Here we performed dual transcriptome analyses on 32 
samples from 46 malaria-infected Gambian children to reveal mechanisms driving the systemic 33 
pathophysiology of severe malaria.  Integrating these transcriptomic data with estimates of parasite 34 
load and detailed clinical information allowed consideration of potentially confounding effects due 35 
to differing leukocyte proportions in blood, parasite developmental stage, and whole-body pathogen 36 
load. We report hundreds of human and parasite genes differentially expressed between severe and 37 
uncomplicated malaria, with distinct profiles associated with coma, hyperlactatemia, and 38 
thrombocytopenia. High expression of neutrophil granule-related genes was consistently associated 39 
with all severe malaria phenotypes. We observed severity-associated variation in the expression of 40 
parasite genes which determine cytoadhesion to vascular endothelium, rigidity of infected 41 
erythrocytes, and parasite growth rate. Up to 99% of human differential gene expression in severe 42 
malaria was driven by differences in parasite load, whereas parasite gene expression showed little 43 
association with parasite load. Co-expression analyses revealed interactions between human and P. 44 
falciparum, with prominent co-regulation of translation genes in severe malaria between host and 45 
parasite. Multivariate analyses suggested that increased expression of granulopoiesis and interferon-46 
γ related genes, together with inadequate suppression of type-1 interferon signalling, best explained 47 
severity of infection. These findings provide a framework for understanding the contributions of host 48 
and parasite to the pathogenesis of severe malaria and identifying targets for adjunctive therapy. 49 
 50 
Introduction 51 
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Most studies of infectious disease pathogenesis focus on either host or pathogen, despite the fact 52 
that outcome is determined by their interaction. Dual RNA-sequencing has been developed as a 53 
method for transcriptomic assessment of such interactions (1, 2), although it has not been widely 54 
applied to study systemic infection in humans. In malaria, the pathogenic stage of the parasite is 55 
restricted to blood where important interactions between parasites and host leukocytes can be 56 
assessed by dual RNA-sequencing (3). The blood is also the conduit for systemic responses to 57 
infection, and gene expression in blood will reflect the inflammatory and metabolic milieu to which 58 
leukocytes and parasites are exposed.     59 
Plasmodium falciparum malaria is one of the most important infectious diseases affecting humans 60 
(3). Most malaria deaths occur in children, in whom three major syndromes are associated with 61 
increased risk of death and distinguish severe malaria from uncomplicated malaria: 1. cerebral 62 
malaria (manifesting as coma), 2. hyperlactatemia / acidosis (often manifesting as deep breathing), 63 
and 3. severe anemia (3-6). These are usually accompanied by the laboratory finding of low platelet 64 
count (thrombocytopenia) (7). Severe malaria syndromes can occur in isolation or in overlapping 65 
combinations (4), and mortality is highest when cerebral malaria and hyperlactatemia / acidosis 66 
coexist (4). Severe malaria is most likely when there is a high parasite load (8-11) and numerous 67 
accompanying pathophysiological derangements have been described (4, 5, 12), broadly arising from 68 
inflammation, vascular endothelial dysfunction and parasite sequestration (accumulation of 69 
parasitized erythrocytes in small blood vessels which obstruct blood flow) (4, 13). These mechanisms 70 
interact with one another, so defining their individual contributions to specific features of severe 71 
malaria is challenging (13, 14). 72 
The host immune response is a major determinant of outcome in rodent models of severe malaria 73 
(15, 16) and it has long been supposed that an excessive host response may also contribute to some 74 
forms of human severe malaria (17, 18). A similar concept exists to explain severity in other 75 
infections such as bacterial sepsis, Ebola and Respiratory Syncytial Virus (19-21), however direct 76 
evidence is often lacking and the confounding effect of pathogen load on the magnitude of the host 77 
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response is rarely quantified. Controlled human infection models have provided insights into the 78 
relationship between pathogen load and early immune responses to infection (22) but cannot be 79 
extended to investigate severe disease. To better understand the pathogenesis of severe infection, a 80 
systemic, integrated view of host-pathogen interaction accounting for variation in pathogen load is 81 
required. 82 
The feasibility of host and parasite dual RNA-sequencing in malaria has been demonstrated in 83 
individuals with uncomplicated malaria (23). Here, we extend the application of dual RNA-84 
sequencing to infectious disease pathogenesis by integrating gene expression analysis with detailed 85 
clinical and laboratory data that characterise the systemic pathophysiology of severe malaria. We 86 
further refine the analysis by accounting for three major confounders which may vary within and 87 
between severity groups. This allows us to characterise human and parasite differential gene 88 
expression between severe and uncomplicated malaria and the role of parasite load in determining 89 
the host response. These data provide a unique insight into host-pathogen interactions associated 90 
with severity of infection in humans and reveal new perspectives on the likely pathogenic 91 
mechanisms of human severe malaria. 92 
 93 
Results 94 
Dual RNA-sequencing and adjustment for cellular heterogeneity 95 
We performed dual RNA-sequencing on whole blood, collected prior to treatment, from 46 Gambian 96 
children with P. falciparum uncomplicated malaria (n = 21) and severe malaria (n = 25) (Table 1). 97 
These children were recruited from a region with relatively low malaria transmission and consistent 98 
with this epidemiology, (4) the severe malaria group contained children with cerebral malaria, 99 
hyperlactatemia, or a combination thereof, but no cases of severe anemia. After exclusion of 100 
parasite var, rifin, stevor (14) and other highly polymorphic regions for which reference genome-101 
based mapping is not possible, we obtained medians of 26.6 million human uniquely mapped reads 102 
from each subject (26.6 million severe malaria, 26.7 million uncomplicated malaria, Mann-Whitney P 103 
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= 0.913) and 9.61 million parasite uniquely mapped reads (10.3 million severe malaria, 5.03 million 104 
uncomplicated malaria, Mann-Whitney P = 0.346) (Fig 1A). We detected expression of 12253 human 105 
and 3880 parasite genes. Commensurate with the high parasitemias seen in these children (Table 1), 106 
parasite read depth was considerably greater than in a previous study of Indonesians with 107 
uncomplicated malaria (23).  108 
Systemic infection provokes changes in blood leukocyte subpopulations which can dominate 109 
changes in gene expression and confound their interpretation (24). Amongst our study subjects 110 
there were significant differences between clinical groups in the proportions of neutrophils (Kruskal-111 
Wallis P = 0.01) and neutrophil counts (Kruskal-Wallis P = 0.05) in blood (Table 1). We performed 112 
gene signature-based deconvolution (25) to estimate heterogeneity in the contribution of the major 113 
leukocyte subpopulations to the RNA in our samples (Fig 1B, fig S1). Parasite gene expression in vivo 114 
is also dominated by the mixture of parasite developmental stages at the time of sampling because 115 
there is phasic variation in gene expression (26) and total RNA content increases during the 116 
intraerythrocytic developmental cycle (27). Therefore we also applied the deconvolution approach 117 
with reference gene signatures derived from highly synchronous parasite cultures (26, 28) to identify 118 
the contribution of parasites at different developmental stages (Fig 1C).  As the method was 119 
developed and validated for distinct human cell types, we confirmed the effectiveness of estimation 120 
of parasite developmental stage mixture by comparison with previously proposed stage-specific 121 
marker genes (29), and by assessment of performance in synthetic datasets of known composition 122 
(fig S2). We compared relative contributions of parasite developmental stages between severe and 123 
uncomplicated malaria samples and observed a trend towards greater contributions from late stage 124 
asexual parasites and gametocytes in children with severe malaria (Fig 1D), consistent with previous 125 
reports (30).  126 
 127 
In order to remove the confounding effect of heterogeneity in leukocyte and parasite mixtures we 128 
adjusted gene expression values for the proportions of detected cell types, essentially allowing us to 129 
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compare gene expression as if all subjects had the same leukocyte and parasite population 130 
compositions.  Adjustment for heterogeneity in the mixture of leukocytes and parasite 131 
developmental stages improved segregation of severe and uncomplicated malaria cases (Fig 1E, F; 132 
multivariate ANOVA for human gene expression P = 0.0013 and P = 0.00012, and for parasite gene 133 
expression P = 0.0049 and P = 0.00019, before and after adjustment, respectively). Therefore we 134 
used adjusted gene expression values for all subsequent analyses. 135 
 136 
Gene expression associated with severe malaria and parasite load 137 
To identify differentially expressed genes between clinical groups, and to identify gene expression 138 
associated with continuous variable severity features, we used a generalised linear model approach 139 
incorporating leukocyte populations or parasite stage as covariates, and we considered a false 140 
discovery rate (FDR)-adjusted P < 0.05 as significant. Considering all subjects, there were 770 human 141 
significantly differentially expressed genes between severe and uncomplicated malaria (Fig 2A, table 142 
S1). Genes more highly expressed in severe malaria versus uncomplicated malaria most notably 143 
included MMP8 (matrix metallopeptidase 8), OLFM4 (olfactomedin 4), DEFA3 (defensin A3), and 144 
ELANE (neutrophil elastase), all encoding neutrophil granule proteins (31). Given our adjustment for 145 
cellular heterogeneity, these results likely reflect a true increase in transcription of these genes 146 
rather than a greater proportion of neutrophils in the blood, and differences remained when 147 
absolute neutrophil counts were multiplied by expression (Fig 2B).  We performed Gene Ontology 148 
(GO) analyses to better understand the biological functions of the differentially expressed genes (Fig 149 
2C) and identified enrichment of co-translational protein targeting, cell motility and immune 150 
response functions (table S2). We used Ingenuity Pathway Analysis (Qiagen Bioinformatics) to 151 
predict upstream regulators of the differentially expressed genes, and colony stimulating factor 3 152 
(CSF3, also known as granulocyte colony stimulating factor, GCSF), Fas cell surface death receptor, 153 
and Prostaglandin E receptor 2 signalling were amongst the most over-represented (table S3). We 154 
repeated similar analyses to identify and interpret genes differentially expressed between 155 
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uncomplicated malaria and different clinical phenotypes of severe malaria (fig S3, tables S1&S2), 156 
which revealed many consistent associations but also some notable differences. For example, the 157 
number of differentially expressed genes substantially increased when comparing the subgroup of 158 
subjects with cerebral malaria plus hyperlactatemia (the most severe phenotype, n = 12) vs 159 
uncomplicated malaria (n=21), possibly reflecting their greater severity and homogeneity of disease 160 
(table S1, figure S3).  The most highly expressed genes in these patients relative to uncomplicated 161 
malaria included genes for neutrophil granules and heat shock proteins.  162 
In order to gain a greater insight into specific pathophysiological processes, we examined the 163 
quantitative association of gene expression with clinical and laboratory parameters (table 1) which 164 
characterise specific aspects of severe malaria pathophysiology: consciousness level (using the 165 
Blantyre Coma Scale, BCS), blood lactate concentration, platelet count and hemoglobin 166 
concentration (table S4). 738 genes were significantly associated with BCS level (using ordinal 167 
regression with FDR P < 0.05, table S4) and decreasing consciousness level (lower BCS) was 168 
associated with both higher expression of genes involved in the cell cycle and lower expression of 169 
genes involved in MHC class I antigen presentation and interferon-γ (IFN-γ) signalling (Fig 2C, table 170 
S2). Predicted upstream regulators included estrogen receptor 1 and transglutaminase 2 (table S3). 171 
1012 human genes were associated with lactate concentration (table S4), amongst which immune 172 
response pathways were again prominent, but a negative association between lactate and type 1 173 
IFN signalling was particularly notable (Fig 2C, table S2), and the most strongly predicted upstream 174 
regulators were IFN-γ, IFN-α, and TNF (table S3).  178 genes were associated with platelet count 175 
(table S4) and the most enriched pathways differed considerably from those in the preceding 176 
analyses (Fig 2C, table S2), with nucleosome assembly (predominantly histone genes), coagulation, 177 
and response to wounding genes all negatively correlated, and the most strongly predicted 178 
upstream regulators being IL13, RB transcriptional corepressor 1, and IL1RN (table S3). No human 179 
genes correlated with hemoglobin concentration. Taken together, these results identify common 180 
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transcriptional features of severe malaria but also implicate distinct mechanisms underlying the 181 
different pathophysiological processes which can occur in severe malaria. 182 
There were 236 parasite genes differentially expressed between severe and uncomplicated malaria 183 
(Fig 2D, table S5). The parasite gene with highest expression in severe relative to uncomplicated 184 
malaria was PF3D7_1016300, a gene which encodes a glycophorin binding protein (GBP) expressed 185 
in the cytoplasm of infected erythrocytes and which influences adhesion and rigidity of the red cell 186 
(32, 33). The most down-regulated parasite gene (with known function) in severe relative to 187 
uncomplicated malaria was PF3D7_1222600 which encodes the AP2 domain transcription factor 188 
AP2-G. This protein controls the balance between gametocytogenesis and asexual replication, and 189 
knockout of the orthologue in P. berghei ANKA enhances the in vivo asexual parasite growth rate 190 
(34, 35).  As with human gene expression, there were more differentially expressed genes in the 191 
comparison of uncomplicated malaria vs. the cerebral malaria plus hyperlactatemia group (fig S3, 192 
table S5). Here the most differentially expressed parasite genes included PF3D7_0202000 (knob-193 
associated histidine rich protein), PF3D7_1016300 (GBP), PF3D7_0201900 (erythrocyte membrane 194 
protein 3), and PF3D7_0424600 (PHIST-b protein), all of which encode proteins that interact with the 195 
erythrocyte cytoskeleton to influence cytoadhesion and deformability of the infected erythrocyte, 196 
making them plausible determinants of severity (33). Parasite genes differentially expressed in 197 
severe compared to uncomplicated malaria were enriched in specific biological functions including 198 
RNA processing, protein transport, and hemoglobin catabolism (Fig 2E, table S6).  199 
445 parasite genes were significantly associated with BCS level (using ordinal regression with FDR P < 200 
0.05), and those most significantly associated with lower BCS were PF3D7_0919800 (TLD domain-201 
containing protein), PF3D7_1133700 (FHA domain-containing protein), and PF3D7_1408200 (AP2 202 
domain transcription factor AP2-G2), the latter two being important determinants of asexual 203 
parasite growth rate (35, 36) (table S7). The most enriched functions associated with BCS included 204 
transport, hemoglobin catabolism and prenylation (Fig 2D). 100 parasite genes associated with 205 
lactate (table S7). The most significant (FDR P = 2.4x10-6) was PF3D7_0201900 (encoding erythrocyte 206 
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membrane protein 3, EMP3), consistent with infected erythrocyte rigidity and cytoadhesion (32, 37, 207 
38) being important determinants of microvascular obstruction and hyperlactatemia (39). Pathway 208 
enrichments amongst these genes differed from those most associated with BCS and included 209 
membrane docking and rRNA processing (Fig 2D and table S6). Few parasite genes were associated 210 
with hemoglobin concentration or platelet count (table S7). Taken together, these findings indicate 211 
that different patterns of parasite gene expression are associated with, and may therefore 212 
contribute to, specific aspects of host pathophysiology. 213 
In order to establish whether changes in parasite gene expression might be cause or consequence of 214 
severe malaria, we tested the effect of hyperlactatemia on parasite gene expression in vitro. 61 215 
genes were differentially expressed between lactate supplemented (n = 4) and control (n = 5) early 216 
ring-stage parasite cultures, particularly enriched in genes associated with transcription and RNA 217 
processing (tables S5 and S6). Two of the genes most highly induced by lactate supplementation 218 
were PF3D7_1016300 (GBP) and PF3D7_0202000 (knob-associated histidine rich protein), genes 219 
which were also highly expressed in the cerebral malaria plus hyperlactatemia phenotype. This 220 
suggests lactate may influence the virulence phenotype of parasites, consistent with a recent report 221 
that Plasmodium can sense and respond to the host metabolic environment (40).  222 
Previous studies have shown a correlation between the expression levels of host genes and 223 
circulating parasitemia (41, 42). Parasite load differed between our subjects with severe and 224 
uncomplicated malaria (Table 1) and we were interested to determine the extent to which this 225 
explained the differences in whole blood gene expression. Peripheral blood parasite quantification 226 
(parasite density) underestimates the total number of parasites in the body because of 227 
sequestration of parasites in the microvasculature (13, 14). The soluble parasite protein, P. 228 
falciparum histidine rich protein 2 (PfHRP2), has been used as a plasma biomarker of total parasite 229 
load (circulating plus sequestered parasites) and is more strongly associated with severity (8, 9, 11) 230 
and death (8, 9). We examined the association of host and parasite gene expression with both 231 
circulating parasite density and PfHRP2 (restricting comparisons to subjects with data for both). We 232 
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found 1886 human genes significantly (FDR P < 0.05) correlated with log parasite density and 616 233 
significantly correlated with log PfHRP2 (102 common to both), whilst only 2 and 10 parasite genes 234 
were significant in the corresponding analyses (none common to both) (tables S4 and S7). Human 235 
genes correlated with log parasite density were particularly enriched in pathways related to 236 
translation (especially exported proteins), oxidative phosphorylation, and antigen presentation (Fig 237 
2F, table S2), with predicted upstream regulation by RPTOR independent companion of MTOR 238 
complex 2 (RICTOR), hepatocyte nuclear factor 4 alpha (HNF4A) and X-box binding protein 1(XBP1); 239 
table S3). Genes correlated with log PfHRP2 were enriched in innate immune response functions (Fig 240 
2F, table S2), and the most strongly predicted upstream regulators were interferon-γ (IFN-γ), 241 
transglutaminase 2, and IFN-α2 (table S3). These findings suggest that the nature of the systemic 242 
host response is associated with the localisation of parasites.  243 
We next asked to what extent the differences in gene expression between severe and 244 
uncomplicated malaria phenotypes were dependent on parasite load. Restricting analyses to 245 
subjects with both parasite density and PfHRP2 measurements, the number of human genes 246 
differentially expressed in severe vs uncomplicated malaria remained almost unchanged after 247 
adjustment for parasite density but was reduced by 98.6% after adjustment for PfHRP2, whilst 248 
parasite differentially expressed genes changed much less after either of the same adjustments 249 
(Table 2, tables S1 and S5). Findings were similar when adjusting for parasite load in comparisons of 250 
each of the severe malaria subtypes vs uncomplicated malaria (tables S1 and S5). Repeating this 251 
analysis on an independent dataset of human microarray gene expression in Malawian children with 252 
cerebral malaria (43) revealed 994 differentially expressed genes (FDR P < 0.05) between children 253 
with (n = 55) and without (n = 17) malaria-associated retinopathy (table S1), with 608 (61%) genes 254 
found to be differentially expressed after adjustment for parasite density, and none differentially 255 
expressed after adjustment for PfHRP2. 256 
Taken together these findings suggest that total body parasite load, as represented by PfHRP2, is a 257 
dominant determinant of host gene expression in malaria, particularly of inflammatory and immune 258 
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response genes, and differences in total body parasite load drive the majority of the human gene 259 
expression differences between severe and uncomplicated malaria. However, if genes remain 260 
associated with severity after adjustment for parasite load, this may indicate intrinsic variation in the 261 
host response which determines susceptibility to severe disease. In our dataset, only 13 genes 262 
remained significant (FDR P < 0.05) after adjustment for PfHRP2 (Table 2, table S1). Of particular 263 
interest amongst these, MMP8 encodes the metallopeptidase MMP8 (also known as collagenase 1) 264 
which causes endothelial barrier damage in several infection models (44, 45); AZI2 encodes 5-265 
azacytidine induced 2 (also known as NF-Kappa-B-Activating Kinase-Associated Protein 1, NAP1) (46), 266 
a regulator of the type 1 interferon response, a pathway which is known to control severity of 267 
disease in rodent malaria models (47); whilst CX3CR1 encodes the receptor for fractalkine (a 268 
biomarker of cerebral malaria in humans (48)), expressed on subset of monocytes which are 269 
particularly efficient at killing malaria parasites (49), and controls the trafficking of monocytes during 270 
inflammation (50).  271 
Parasite load was also a major driver of the associations between human gene expression and BCS 272 
level, lactate, and platelet count, although platelet count-associated genes were relatively less 273 
dependent on parasite load (Table 2). The few remaining genes significantly associated with lactate 274 
after adjustment for PfHRP2 included PKM (encoding the glycolytic enzyme pyruvate kinase M) and 275 
GYS1 (encoding the glycogenic enzyme glycogen synthase 1) (table S4), suggesting hyperlactatemia 276 
is partly associated with parasite load-independent variation in control of host glucose metabolism.  277 
 278 
Co-expression networks of host and parasite genes 279 
The expression of genes with common functional roles is often correlated and can be identified 280 
through co-expression network analysis (51). We applied this methodology to paired host and 281 
parasite gene expression data from each individual (without prior adjustment for parasite load) to 282 
identify co-expressed groups of genes from either or both species. We term these groups of genes 283 
“modules”, and we named each module according to the “hub gene” which has the greatest 284 
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connectivity to other genes within the module. First we analysed all subjects together, generating a 285 
network with 26 modules (Fig 3 and table S8): 10 modules contained exclusively human genes, 5 286 
exclusively parasite genes, and 11 both human and parasite genes (most of these highly skewed to a 287 
single species). Only the HSPH1 (heat shock protein family H [Hsp110] member 1) module contained 288 
more than 10 genes from both human and parasite, and was strongly enriched in human heat shock 289 
response and parasite RNA metabolism genes. All modules showed significant (P < 0.05) GO 290 
enrichments, regardless of host or parasite origin. The composite expression of genes within a 291 
module can be described by a module eigengene value (51, 52) and there were associations 292 
between module eigengene values and malaria severity, parasite load, consciousness level, and 293 
other laboratory parameters (Figure 3). Some host-dominated and parasite-dominated modules 294 
were also highly correlated with each other, most notably the RPL24 (ribosomal protein L24) module 295 
(highly enriched in translation pathways) strongly correlated with the functionally similar 296 
PF3D7_0721600 (putative 40S ribosomal protein S5) parasite module. We excluded multi-mapping 297 
reads as an explanation for this, and suggest that this indicates co-regulation of conserved host and 298 
parasite translation machinery. Furthermore, most of these genes were also differentially expressed 299 
between severe and uncomplicated malaria.  300 
 301 
Association of co-expression modules with severity 302 
Co-expression network modules can be used as units of analysis, affording considerable dimension 303 
reduction for whole-genome expression data. We used module eigengene values and parasite load 304 
(with which many modules were correlated, Fig 3) in linear regression models to determine the best 305 
within-sample predictors of severity, starting with all significant (P < 0.01) univariate associations 306 
and proceeding by backward selection (table S9). The resulting multivariate model combined MMP8, 307 
OAS1 (2'-5'-oligoadenylate synthetase 1) and LYSMD3 (LysM, putative peptidoglycan-binding, 308 
domain containing 3) module eigengenes, but not parasite load. In fact, these modules represent 309 
distinct aspects of the immune response (table S8): the MMP8 module, highly enriched in defence 310 
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response genes with predicted upstream regulators CEBPA (CCAAT/enhancer binding protein alpha, 311 
a myeloid transcription factor) and CSF3, likely reflects granulopoiesis (31); the OAS1 module is 312 
highly enriched for type-1 IFN response genes; and the small LYSMD3 module, with limited GO 313 
enrichment, contains a functional network around IFN-γ (figure S4). The direction of association of 314 
the OAS1 module with severity changed from negative in univariate analysis to positive in the 315 
multivariate analysis, suggesting that inadequate suppression of the type-1 IFN response in 316 
conjunction with upregulation of granulopoiesis and IFN-γ signalling may contribute to pathogenesis.   317 
 318 
Differential co-expression in severe malaria 319 
Considering all subjects together in the generation of co-expression networks maximises power to 320 
detect consistently co-regulated genes but may not identify sets of genes where co-regulation is 321 
altered by severity. For this reason we also created separate co-expression networks for 322 
uncomplicated and severe malaria and compared modules to identify differential co-expression (Fig 323 
4, table S10). Eight modules showed substantial preservation between networks, seven were 324 
partially preserved, and two were unique to severe malaria (Figure 4A). Partial preservation was 325 
common amongst modules comprised predominantly from human or parasite genes (Figure 4A,B), 326 
and module preservation was not dependent on the proportion of module genes differentially 327 
expressed between severe and uncomplicated malaria (Figure 4A,C).  A MMP8 module (exclusively 328 
human genes, many encoding neutrophil granule and phagosome components) was uniquely 329 
present in severe malaria subjects, and 38% of its member genes were differentially expressed in the 330 
comparison between severe malaria and uncomplicated malaria (table S10). The module was 331 
enriched in host defence functions and predicted to be regulated by CEBPA, CSF3 and TNF (table 332 
S10). These findings strongly suggest the MMP8 module represents emergency granulopoiesis (31) 333 
and mark this as a specific feature of severe malaria. The TIPRL (TOR Signaling Pathway Regulator) 334 
module (99.2% human genes) was also unique to severe malaria but contained very few (1.3%) 335 
differentially expressed genes, had limited GO enrichment, and the most strongly predicted 336 
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upstream regulator was the transcription factor HNF4A (table S10). Both TIPRL and HNF4A have 337 
regulatory roles in metabolic, inflammatory and apoptosis signal pathways, so the minimal change in 338 
expression of this module may represent an aberrant response in severe malaria (53, 54). Amongst 339 
the partially preserved modules we observed that host and parasite translation pathways were more 340 
tightly co-regulated in severe than uncomplicated malaria, with genes being distributed across fewer 341 
modules in severe malaria (Fig 4A, table S10). This once again suggests that there is an interaction 342 
between these processes that is associated with severity. 343 
 344 
Interaction of parasite and host gene expression accounting for parasite load 345 
We sought to integrate pathogen load into analysis of interaction between host and parasite gene 346 
expression. To reduce dimensionality we generated human-only gene expression modules from all 347 
subjects (table S11), identified those modules significantly (P < 0.05) associated with severity, and 348 
then identified parasite genes with significant (FDR P < 0.05) pairwise associations with these 349 
modules in a linear model accounting for log PfHRP2.  The human modules associated with severity 350 
were similar to those identified in preceding analyses (Table 3). The most significantly associated 351 
parasite genes and the most enriched parasite GO terms were those involved in RNA processing and 352 
translation (Table 3, table S11), suggesting that these processes in the parasite drive multiple aspects 353 
of the host transcriptional response independent of their effect on parasite load.     354 
 355 
Neutrophil-related proteins in plasma 356 
The most differentially expressed genes in comparisons between severe and uncomplicated malaria 357 
encode neutrophil granule proteins (figure 2A). Relationships between transcription, translation, 358 
storage and release of granule proteins are expected to be complex, but we sought evidence of 359 
correlation between gene expression and circulating protein concentrations. In subjects with 360 
residual stored plasma we found significant correlations between gene expression and plasma 361 
concentrations of defensin A3 (P = 0.0049, rho =0.47, n = 34) and elastase (P = 0.045, rho = 0.35, n = 362 
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34) (figure S5). MMP8 expression was significantly correlated with plasma concentrations in subjects 363 
with severe malaria (P = 0.02, rho = 0.59, n = 15), but not in uncomplicated malaria (P = 0.37, rho =  -364 
0.21, n = 20) or all subjects combined (P = 0.88 , rho = -0.026, n = 35). Upstream regulator analyses 365 
described earlier suggested that GCSF (CSF3) was a major regulator of genes in the MMP8 module. 366 
We found that plasma GCSF concentrations significantly correlated with the eigengene values (table 367 
S8) for this module (P = 0.0030, rho = 0.64, n = 19). We tested whether neutrophil degranulation 368 
occurred in response to parasite material by stimulating healthy donor blood cells with P. falciparum 369 
schizont lysate, and detected increases in MMP8 release, reaching similar concentrations to those 370 
observed in plasma during malaria (figure S5). 371 
 372 
Discussion  373 
We used dual RNA-sequencing to identify simultaneous host and parasite gene expression and their 374 
systemic interactions associated with severity of P. falciparum malaria in humans. Whilst gene 375 
expression is only one of the many biological processes involved, our findings add to the argument 376 
for an integrated understanding of infectious diseases and make a strong case that neither host nor 377 
pathogen should be studied in isolation when possible.  378 
We have identified many associations between gene expression and features of severity, providing 379 
plausible insight into the pathogenesis of severe malaria (figure S6). One of our most striking findings 380 
was the overriding effect of parasite load on differences in human gene expression between severe 381 
and uncomplicated malaria. Previous studies have examined the association between human gene 382 
expression and circulating parasitemia (23, 41, 42), but we found that estimation of total body (both 383 
circulating and sequestered) parasite load was necessary to appreciate the full effect on host 384 
response. Our findings imply that the host response in severe malaria is not excessive per se, but 385 
rather that it is an appropriate host response to an excessive pathogen load. This has important 386 
implications for malaria research and likely for other infectious disease, immunology, and 387 
pathogenesis research in humans. Without accounting for pathogen load, associations between host 388 
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factors (such as genetic variants or comorbidities) and severity of infection may be misinterpreted. 389 
Unfortunately, total body pathogen load is much harder to measure in other infections in humans 390 
where pathogens are not restricted to the blood (55).We found that specific sets of host and 391 
parasite genes were associated with different pathophysiological consequences of malaria, although 392 
our power to detect associations was limited in the smallest subgroup analyses. Distinct sets of host 393 
genes were associated with BCS, lactate concentration and platelet count. Hyperlactatemia in 394 
malaria is often ascribed to anaerobic metabolism arising from microvascular obstruction by 395 
adherent and rigid parasitized erythrocytes (4, 39).  These properties are partly determined by the 396 
expression of particular members of the var, rif and stevor gene families (14), which we did not 397 
include in our analysis because their extreme degree of polymorphism prevents reference genome-398 
based quantification. Despite this limitation we still found associations between lactate 399 
concentration and severity and in vivo variation in the expression of other parasite genes known to 400 
modify the biophysical properties of the infected erythrocyte. Some variation in parasite gene 401 
expression may have a genetic basis (56) but our in vitro data suggests that it may also occur as a 402 
response to the host environment.  403 
The human genes most correlated with lactate were immune response-related, suggesting that 404 
inflammation, and perhaps its effect on glycolysis, may be involved (57, 58). If lactate production is 405 
associated with the strength of the host response then the changes in expression of parasite genes 406 
in response to lactate might favour sequestration and evasion of innate immune cells as a parasite 407 
survival strategy. Cerebral malaria in humans is usually ascribed to parasite sequestration in the 408 
cerebral microvasculature, but the association between BCS and antigen presentation via MHC class 409 
I, interferon-γ, and type-1 interferon signalling, would be consistent with the localisation of these 410 
immunopathological mechanisms away from the blood and into the brain microvasculature as seen 411 
in rodent experimental cerebral malaria (15, 16, 59). Thromobocytopenia is almost invariable in 412 
malaria and its mechanism is poorly understood (7). Our findings implicate the well-recognised 413 
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activation of endothelial surfaces and coagulation pathways in malaria (7) as a cause, but also lead 414 
us to suspect a role for histone-induced thrombocytopenia (60, 61).  415 
Many of our results converge on a putative role for neutrophils in severe malaria. Different analytical 416 
approaches repeatedly identified the association of genes encoding neutrophil granules (such as 417 
MMP8, OLFM4, DEFA3, ELANE) and upstream regulators of granulopoiesis (CSF3 and CEBPA) with 418 
severe outcomes.  Granule proteins are enriched in immature neutrophils (31, 62) which are 419 
mobilised from the bone marrow to the circulation in malaria (63, 64), and there is plentiful 420 
evidence that neutrophil degranulation occurs in severe malaria (43, 65). Release of neutrophil 421 
granule proteins can be highly damaging to host tissues (62), and increased production and release 422 
of these proteins could contribute to many of the pathological features of severe malaria. Both 423 
neutrophil granule proteins and histones are released into the circulation during production of 424 
neutrophil extracellular traps (NETs) (62, 66), a phenomenon which has been described in malaria 425 
(64). It is noteworthy that similar neutrophil-related signatures are not reported in the whole blood 426 
transcriptomes of rodent models which have been examined to date (42, 67), creating a challenge 427 
for experimental validation. However, neutrophil depletion has been shown to prevent experimental 428 
cerebral malaria (68), and whilst this is not a viable therapeutic option in humans, pharmacological 429 
inhibitors of specific neutrophil functions such as NETosis are being evaluated in other diseases (66). 430 
We observed a relationship between type-1 IFN responses and severity of malaria, which may help 431 
to tie together data from previous observations in humans and animal models. In a small study, 432 
expression of type-1 IFN response genes in blood from uncomplicated malaria was higher than in 433 
severe malaria, leading to the suggestion that this may be protective against developing severe 434 
malaria (69). However, we found that type-1 IFN response genes were negatively correlated with 435 
parasite load, suggesting down-regulation with increasing parasite load (and severity) is a more likely 436 
explanation. Our multivariate analyses using gene expression modules to explain severity suggested 437 
that insufficient suppression of type-1 IFN signalling was in fact associated with severity. This would 438 
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be more consistent with results in mouse malaria models where genetic or antibody-mediated 439 
ablation of type-1 IFN signalling improves outcome (70-73).   440 
Very few parasite genes correlated with parasite load at the time of clinical presentation. This may 441 
be a consequence of the dynamic nature of parasite load, which is determined by parasite growth 442 
rate, the number of replication cycles in the host (duration of infection), and a reciprocal interaction 443 
with the constraining host response. Thus lower expression of the gene encoding ApiAP2-G in severe 444 
malaria may increase the asexual parasite growth rate (34) and make severe malaria more likely, 445 
without this gene exhibiting any correlation with parasite load. It may also seem paradoxical that 446 
this gene is down-regulated in severe malaria given that gametocytes are usually more common in 447 
severe malaria (30). Development of mature gametocytes takes 10-12 days, for much of which they 448 
are not in the systemic circulation (74). We speculate that the mature gametocytes detected at the 449 
time of clinical presentation may reflect preferential gametocytogenesis in early infection and 450 
perhaps a subsequent reduction in ApiAP2-G that promotes enhanced asexual replication and severe 451 
disease.  452 
We noted that both human and parasite translation pathways were associated with severe malaria, 453 
and these pathways showed the strongest evidence of interaction between species, with co-454 
regulation appearing tighter in more severe disease. Increased translation is important for 455 
production of host defence effector proteins (75) and parasite proteins which enable survival (76) 456 
and it is feasible that these processes drive each other. This raises the intriguing question of whether 457 
addition of a translation inhibiting anti-malarial such as mefloquine (77) to standard artesunate 458 
treatment may have added benefit in severe malaria.  459 
The differences in human and parasite gene expression between severe and uncomplicated malaria 460 
were much clearer after adjusting for heterogeneity of leukocyte population and parasite 461 
developmental stage. Although the importance of accounting for such variation is well recognised 462 
(24), it is rarely done in infectious disease transcriptomic studies. Several studies have used 463 
alternative methods to account for parasite developmental stage distribution and have shown that 464 
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this has a major impact on observed associations between parasite gene expression and clinical 465 
phenotype (78, 79).  466 
Whilst we cannot establish causation from an observational study such as this, our findings should 467 
be launch points for future work assessing the implicated mechanisms and their potential as targets 468 
for adjunctive therapies. The identification of multiple and sometimes distinct host and parasite 469 
mechanisms associated with differing aspects of pathophysiology potentially bodes ill for adjunctive 470 
therapies, which might need to have multiple targets and perhaps be personalized to differing 471 
severe malaria manifestations. However the common association of neutrophil granule protein 472 
genes with all severe malaria manifestations suggests that targeting neutrophil function may be a 473 
therapeutic strategy in the future.  474 
  475 
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Materials and Methods 476 
Detailed Supplementary Methods are available on-line 477 
Study design 478 
The primary aim of the study was to analyse differential human and parasite gene expression 479 
between children with severe malaria and uncomplicated malaria and to determine association of 480 
gene expression with parasite load. Secondary aims were 1) to analyse differences in gene 481 
expression associated with different severe malaria syndromes and with continuous variable 482 
markers of pathophysiology, 2) to evaluate co-expression of host and parasite genes, and 3) to 483 
evaluate differential co-expression associated with severe malaria.  Sample size was determined 484 
pragmatically based on the availability of suitable samples with necessary clinical and laboratory 485 
data. We aimed to achieve close to 30 million mapped human reads and 5 million mapped parasite 486 
reads per sample and calculated the likely number of reads required to achieve this based on the 487 
percentage parasitemia in each subject and the likely amount of RNA per ring-stage parasite (27). 488 
From available RNA samples we aimed to have roughly equal numbers of severe and uncomplicated 489 
malaria cases and within the severe malaria cases we aimed to have eight subjects with each 490 
phenotype. After assessment of RNA quantity and quality some samples were unsuitable for RNA-491 
sequencing which resulted in the final composition of groups being slightly unbalanced. 492 
Subjects and samples  493 
Gambian children (under 16 years old) with P. falciparum malaria were recruited as previously 494 
described (11, 80, 81). Informed consent was obtained and the study was approved by the Gambian 495 
Government / MRC Laboratories Joint Ethics Committee (SCCs 670, 1077, 1143, 1178, 1179, 1180, 496 
1207 and L2013.07V2). Malaria was defined by fever and >5000 asexual parasites/μL of blood. 497 
Cerebral malaria was defined as BCS of 1 or 2, or a BCS of 3 if the motor response was 1, not due to 498 
other causes (11, 80). Hyperlactatemia / acidosis was defined as blood lactate concentration > 499 
5mmol/L (11).  Subjects meeting both criteria were described as having cerebral malaria plus 500 
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hyperlactatemia / acidosis. Blood was collected at the time of presentation to the clinic, prior to any 501 
treatment (80).  502 
For RNA-sequencing, severe and uncomplicated malaria groups were matched as closely as possible 503 
by age and gender (Supplementary Dataset 1). For uncomplicated malaria samples we aimed to 504 
include an equal number with parasitemia above and below 5%.  505 
RNA-sequencing  506 
RNA was collected and extracted as described previously (80). 1μg of total RNA was used with the 507 
ScriptSeq v2 RNA-sequencing library preparation kit (Illumina) and ribosmal RNA (rRNA) and globin 508 
messenger RNA (mRNA) were depleted using the Globin-Zero Gold kit (Epicentre). Strand-specific 509 
libraries were sequenced using the 2x100 bp protocol with an Illumina HiSeq 2500.  510 
Genomes and RNA annotations  511 
Reference genomes were obtained for human (hg38) (82) and P. falciparum (release 24) (83), and 512 
gene annotations were obtained from GENCODE (release 22) (84) and PlasmoDB (release 24) (83). 513 
Statistical analysis 514 
Characteristics were compared between subject groups using the Kruskal-Wallis or Mann-Whitney 515 
tests for continuous data and Fisher’s exact test for categorical data. The Wilcoxon matched pairs 516 
test was used to compare paired data. Correlations were performed using Spearman correlation or 517 
Pearson correlation (when data was normally distributed). To determine genome-wide gene 518 
expression associated with variables of interest, P-values were calculated for individual genes as 519 
described in the Supplementary Methods, and a false-discovery rate adjusted P < 0.05 was 520 
considered significant. Fisher’s exact test was used to identify gene set enrichments. Logistic 521 
regression was used to determine associations between severity and module eigengene values. 522 
 523 
  524 
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Supplementary Materials 525 
 526 
Supplementary Materials and Methods 527 
 528 
Fig S1. Estimates of the relative proportions of leukocyte subpopulations in subjects with severe 529 
and uncomplicated malaria.  530 
  531 
Fig S2. Validation of the gene-signature approach to estimate parasite developmental stage 532 
proportions.  533 
  534 
Fig S3. Differential gene expression between severe malaria phenotypes and uncomplicated 535 
malaria.  536 
  537 
Fig S4. Top functional network for the small LYSMD3 module.  538 
 539 
Fig S5. Association between gene expression and plasma protein concentrations.  540 
 541 
Fig S6. Host pathogen-interactions in severe malaria revealed through dual RNA-sequencing. 542 
 543 
Table S1. Human genes differentially expressed between malaria disease phenotypes in 544 
unadjusted and parasite load-adjusted analyses. 545 
  546 
Table S2. Gene ontology terms associated with human differentially expressed or significantly 547 
correlated genes in unadjusted and parasite load-adjusted analyses.  548 
 549 
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Table S3. Predicted upstream regulators associated with human differentially expressed or 550 
significantly correlated genes in unadjusted and parasite load-adjusted analyses.  551 
 552 
Table S4. Human genes significantly correlated with parasite load and pathophysiological variables 553 
in unadjusted and parasite load-adjusted analyses.  554 
 555 
Table S5. P. falciparum genes differentially expressed in unadjusted and parasite load-adjusted 556 
analyses. 557 
  558 
Table S6. Gene ontology terms associated with parasite differentially expressed or significantly 559 
correlated genes in unadjusted and parasite load-adjusted analyses. 560 
 561 
Table S7. P. falciparum genes significantly correlated with parasite load and pathophysiological 562 
variables in unadjusted and parasite load-adjusted analyses. 563 
 564 
Table S8. Summary of modules obtained from combined whole genome correlation network.  565 
 566 
Table S9. Univariate and multivariate associations of module eigengene values and parasite load 567 
with severity. 568 
  569 
Table S10. Summary and overlap of whole genome correlation sub-networks for severe and 570 
uncomplicated malaria.  571 
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 892 
 CM (n = 5) CH (n = 12) HL (n = 8) UM (n = 21) P  
Age (years) 4.3 (4.2-4.8) 4.9 (3.6-5.7) 5.0 (3.8-8.3) 6.0 (4.0-9.0) 0.51 
Male (%) 3 (60%) 5 (42%) 7 (88%) 13 (62%) 0.24 
Parasitemia 
(%) 
8.3 (5.3-9.0)4 12.6 (9.4-19.0) 9.6 (1.8-12.2) 5.1 (3.8-7.0) 0.008 
Parasites  
(x105 /uL) 
2.3 (1.7-3.1) 3 3.5 (2.7-8.4) 11 2.8 (0.7-5.0) 2.3 (1.6-3.2) 0.062 
 
Clones 2 (1.5-2.5) 4 2 (1-2) 9 1 (1-2) 5 2 (1-2) 15 0.67 
PfHRP2 
(ng/mL) 
202 (93-528) 4 763 (374-1750) 470 (164-2214) 163 (128-227) 0.004 
Duration of 
illness (days) 
2.0 (1.7-3.0) 2.0 (2.0-2.5) 2.0 (2.0-3.5) 2.7 (2.0-3.0) 0.22 
Hb (g/dL) 9.7 (7.4-10.4) 9.3 (7.8-11.5) 11 9.1 (7.4-11.0) 10.8 (9.9-12.1) 0.12 
 
WBC (x109/L) 9.8 (8.2-12.9) 4 8.8 (6.4-9.4) 11 15.3 (7.9-16.8) 
7 
9.5 (7.7-11.8) 0.41 
 
Platelets 
(x109/L) 
41 (40-82) 4 36 (23-65) 11 59 (33-132) 122 (96-132) 0.013 
Lymphocytes 
(x109/L) 
2.7 (2.1-3.6)4 2.9 (2.4-3.6)11 3.1 (1.8-5.2)7 2.4 (1.4-3.1)20 0.57 
Lymphocyte 
(%) 
29.8 
(20.6-37.3) 4 
37.8 
(29.9-49.9)11 
22.3 
(14.7-37.3)7 
23.9 
(16.0-33.5)20 
0.087 
Neutrophils 
(x109/L) 
6.4 (4.0-8.7)4 4.0 (2.9-4.3)10 6.5 (5.8-10.4)7 7.0 (5.3-7.7)20 0.045 
Neutrophil  
(%) 
55.1 
(49.0-69.6) 4 
48.3 
(39.6-56.2) 10 
61.5 
(55.6-74.9) 7 
68.0 
(59.9-79.6)20 
0.016 
Monocytes 
(x109/L) 
0.6 (0.6-0.7)4 0.6 (0.5-0.9)10 0.8 (0.6-1.3)7 0.7 (0.4-0.9)20 0.58 
Monocyte  
(%) 
7.1 
(6.0-7.7)4 
7.8 
(6.8-8.6)10 
6.6 
(5.1-7.8) 7 
6.7 
(4.8-7.3)20 
0.12 
Table 1. Characteristics of study subjects (n = 46). CM, cerebral malaria; CH, cerebral malaria plus 893 
hyperlactatemia; HL, hyperlactatemia (CM, CH, and HL are all subgroups of severe malaria); UM, 894 
uncomplicated malaria; PfHRP2, P. falciparum histidine rich protein 2; Hb, hemoglobin 895 
concentration; WBC, white blood cell count. Data are median (IQR), superscripts indicate the 896 
number of subjects with data for each variable if less than the total; P for Kruskall-Wallis test 897 
39 
 
comparing all groups (degrees of freedom = 3) except for sex where P is for Fisher’s exact test. 898 
Leukocyte population numbers and proportions measured by clinical hematology analyser. 899 
  900 
40 
 
 901 
 Human genes Parasite genes 
 
n* Unadjusted 
Log 
parasite  
density 
Log 
PfHRP2 n* Unadjusted 
Log 
parasite  
density 
Log 
PfHRP2 
SM vs UM 43 907 914 
(101%) 
13 
(1.4%) 
41 516 562 
(109%) 
329 
(64%) 
BCS 43 738 491 
(67%) 
12 
(1.6%) 
41 445 
 
340 
(76%) 
148 
(33%) 
Lactate 40 1012 526 
(52%) 
51 
(5.0%) 
38 100 109 
(109%) 
47 
(47%) 
Platelets 43 178 66 
(37%) 
46 
(25%) 
41 1 1 
(100%) 
1 
(100%) 
Hemoglobin 43 0 0 0 41 6 5 
(83%) 
4 
(67%) 
Table 2. Numbers of differentially expressed genes before and after adjustment for parasite load. 902 
*Only subjects with complete data for every parameter are included. Number of genes associated 903 
with severity category or laboratory marker of severity before and after adjustment for parasite load 904 
(% of number in unadjusted analysis where applicable). BCS, Blantyre coma scale; SM, severe 905 
malaria; UM, uncomplicated malaria. 906 
  907 
41 
 
 908 
Human Module Correlated parasite genes after adjustment for parasite load 
Hub gene Top GO 
term 
n 
(+/-) 
Top genes FDR P Top GO terms P 
Receptor 
Transporter 
Protein 4 
(RTP4) 
GO:0034340
response to 
type I 
interferon 
2 
(2/0) 
 
PF3D7_0827500 (apicoplast 
ribosomal protein L21 
precursor) 
0.014 
 
GO:0006412 
translation 
0.018 
PF3D7_0111800 (eukaryotic 
translation initiation factor 
4E) 
0.035 
Trinucleotide 
Repeat 
Containing 6B 
(TNRC6B) 
GO:0016569
chromatin 
modification 
97 
(29/ 
68) 
PF3D7_1119200 (unknown 
function) 
0.000
12 
GO:0008380 
RNA splicing 
4.15 
x10-6 
PF3D7_1309100 (60S 
ribosomal protein L24) 
0.000
27 
GO:0006396 
RNA 
processing 
3.88 
x10-5 
PF3D7_0825500 (protein 
KRI1) 
0.000
36 
  
Heat shock 
protein family 
H (Hsp110) 
member 1 
(HSPH1) 
 
GO:0006457
protein 
folding 
21 
(17/ 
4) 
PF3D7_0933100 (unknown 
function) 
0.007
1 
GO:0000338 
protein 
deneddylation 
0.0038 
PF3D7_1118400 (haloacid 
dehalogenase-like hydrolase) 
0.007
9 
PF3D7_0521800 (AFG1-like 
ATPase) 
0.01 
Matrix 
metallopeptid
-ase 8 (MMP8) 
GO:0009617
response to 
bacterium 
18 
(16/ 
2) 
PF3D7_1356200 
(mitochondrial import inner 
membrane translocase 
subunit TIM23) 
0.004
5 
GO:0019219 
regulation of 
nucleobase-
containing 
0.0065 
42 
 
PF3D7_1119100 (tRNA m(1)G 
methyltransferase) 
0.007
1 
compound 
metabolic 
process PF3D7_0823100 (RWD 
domain-containing protein) 
0.007
3 
Peptidylprolyl 
isomerase B 
(PPIB) 
GO:0034976
response to 
endoplasmic 
reticulum 
stress 
24  
(24/ 
0) 
PF3D7_1420300 (DNL-type 
zinc finger protein) 
0.002
2 
GO:0006364 
rRNA 
processing 
0.0058 
PF3D7_0821200 (unknown 
function) 
0.005
7 
PF3D7_1119200 (unknown 
function) 
0.005
7 
Ribosomal 
protein L24 
(RPL24) 
GO:0006614
SRP-
dependent 
co-
translational 
protein 
targeting to 
membrane 
93 
(78/ 
15) 
PF3D7_0530600 (XAP-5 DNA 
binding protein) 
5.3 
x10-6 
GO:0006396 
RNA 
processing 
6.92 
x10-4 
PF3D7_1309100 (60S 
ribosomal protein L24) 
5.3 
x10-6 
GO:0008380 
RNA splicing 
1.10 
x10-3 
PF3D7_0821200 (unknown 
function) 
3.3 
x10-5 
  
Table 3. Parasite genes correlated with human gene co-expression modules after adjustment for 909 
parasite load. +/- indicates number of parasite genes positively / negatively correlated with each 910 
human module eigengene value. All “top genes” in the table are positively correlated with the 911 
module eigengene value.  912 
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913 
Figure 1. Whole blood dual RNA-sequencing and deconvolution. (A) Uniquely mapped reads from 914 
human (red) and P. falciparum (blue) from subjects with severe (SM, n = 25) and uncomplicated 915 
malaria (UM, n = 21). (B,C) Heatmaps showing signature gene expression for different leukocyte (B) 916 
and parasite developmental stage (C) populations and their relative intensity in individual subjects 917 
with SM, including different SM phenotypes (CH, cerebral malaria plus hyperlactatemia; CM, 918 
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cerebral malaria; HL, hyperlactatemia), and UM.  (D) Surrogate proportion variables for parasite 919 
developmental stages compared between severe malaria and uncomplicated malaria using the 920 
Mann-Whitney test (bold line, box and whiskers indicate median, interquartile range and up to 1.5-921 
times interquartile range from the lower and upper ends of the box respectively). (E,F) Principal 922 
component plots showing the effect of deconvolution on the segregation of subjects with UM and 923 
SM, adjusting human (E) and parasite (F) gene expression for differences in proportions of 924 
leukocytes or parasite developmental stages respectively. Analyses of human gene expression (B,E): 925 
SM, n = 25; UM, n = 21.  Analyses of parasite gene expression (C,D,F): SM, n = 23; UM, n = 20. 926 
  927 
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928 
Figure 2. Association of gene expression with features of severe malaria and parasite load. (A) 929 
Volcano plot showing extent and significance of up- or down- regulation of human gene expression 930 
in severe malaria (SM) compared with uncomplicated malaria (UM) (red and blue, P <0.05 after 931 
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Benjamini-Hochberg adjustment for false discovery rate [FDR]; orange and blue, absolute log2-fold 932 
change (FC) in expression > 1; SM n = 25, UM n = 21). (B)  Comparison of selected neutrophil-related 933 
gene expression multiplied by absolute neutrophil count in blood between SM (n = 21) and UM (n = 934 
20) (bold line, box and whiskers indicate median, interquartile range and up to 1.5-times 935 
interquartile range from the lower and upper ends of the box respectively, P for Mann-Whitney 936 
test). (C) Heatmap comparing enrichment of gene ontology terms for human genes significantly 937 
differentially expressed between severe malaria and uncomplicated malaria or significantly 938 
associated with blood lactate, platelet count or BCS. (D) P. falciparum differential gene expression in 939 
severe malaria compared to uncomplicated malaria (colour coding as in (A); SM n = 23, UM n = 20).  940 
(E) Heatmap comparing enrichment of gene ontology terms for parasite genes significantly 941 
differentially expressed between severe malaria and uncomplicated malaria and or significantly 942 
associated with blood lactate or BCS. (F) Heatmap comparing gene ontology terms for human genes 943 
significantly associated with log parasite density and log PfHRP2.   944 
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Figure 3. Interspecies gene expression modules and their associations with severity.  Circos plot 946 
showing gene expression modules obtained from whole genome correlation network analysis using 947 
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expression of all human and parasite genes from each subject (severe malaria, n = 22; 948 
uncomplicated malaria, n = 19) as the input. From outside to inside: labels, hub gene and most 949 
enriched GO term (with P-value) for each module; track 1, module eigengene value for each subject; 950 
track 2, clinical phenotype (Red, CH; Orange, CM; Green, HL; Yellow, uncomplicated malaria); track 3, 951 
hub gene expression (log CPM) for each subject; track 4, heatmap for correlation with laboratory 952 
measurements (clockwise, blocks: log parasite density, log PfHRP2, lactate, platelets, hemoglobin, 953 
BCS; colour intensity represents correlation coefficient as shown in colour key); track 5, module size 954 
and composition (length proportional to number of genes in module; red, human genes; blue, 955 
parasite genes); polygons connect modules with significant (FDR P < 0.01) Pearson correlation 956 
between eigengene values (width proportional to -log10 FDR P-value; red=positive correlation, 957 
blue=negative correlation).    958 
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959 
Figure 4. Severity-associated differential co-expression within the interspecies gene expression 960 
network. (A-C) Cytoscape visualisation of merged co-expression networks derived separately from 961 
severe malaria (n = 22) and uncomplicated malaria (n = 19). Networks were merged such that genes 962 
found in both sub-networks (represented as arrow-shaped, larger-sized nodes) are connected to 963 
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genes found in only one sub-network (represented as circular-shaped and smaller-sized nodes). (A) 964 
Genes and gene clusters are coloured and annotated by module, species, most enriched gene 965 
ontology terms, and conservation between sub-networks. Preserved, module pairs from severe 966 
malaria and uncomplicated malaria sub-networks overlap with each otherbut no other modules; 967 
partially preserved, module clusters in one sub-networkoverlap with two or more modules in the 968 
other sub-network; unique, gene clustering only found in one sub-network. Genes in black do not 969 
belong to any characterized module. (B) Identical network layout with genes coloured by species 970 
(red, human; blue, P. falciparum). (C) Identical network layout with genes coloured by whether they 971 
are significantly differentially expressed in severe malaria vs uncomplicated malaria (red, human; 972 
blue, P. falciparum; black, not differentially expressed). 973 
